Direct Digital Holdings (DRCT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for December 27, 2024, to be held virtually, with voting on key proposals including director elections, auditor ratification, incentive plan amendment, and share issuance under an equity facility.
Record date for voting is November 5, 2024; stockholders can vote online, by mobile, or by mail, and may revoke proxies before or during the meeting.
Board recommends voting in favor of all proposals on the agenda.
Voting matters and shareholder proposals
Election of five directors for a one-year term until the 2025 Annual Meeting.
Ratification of BDO USA, P.C. as independent registered public accounting firm for 2024.
Amendment to the 2022 Omnibus Incentive Plan to increase Class A common stock issuable by 2,000,000 shares.
Approval of issuance of up to 8,500,000 shares of Class A common stock under the Equity Reserve Facility, in accordance with Nasdaq rules.
Board unanimously recommends voting “FOR” all proposals.
Board of directors and corporate governance
Board consists of five members, including CEO Mark D. Walker (Chairman), President Keith W. Smith, and three independent directors.
Board committees: Audit, Compensation, and Nominating & Corporate Governance, all comprised of independent directors.
Lead independent director presides over meetings of independent directors.
Board diversity matrix disclosed, with representation across gender and ethnic backgrounds.
Directors expected to attend all board and committee meetings; all attended at least 75% in 2023.
Latest events from Direct Digital Holdings
- Executing a turnaround with direct DSP integrations after a 2024 revenue dip.DRCT
Investor presentation10 Feb 2026 - Shelf registration allows up to $400M in securities to fund growth amid ongoing industry risks.DRCT
Registration Filing10 Feb 2026 - Digital ad platform seeks up to $100M via equity facility amid liquidity and operational risks.DRCT
Registration Filing4 Feb 2026 - Q3 revenue plunged 85% year-over-year, with recovery and liquidity actions underway.DRCT
Q3 202414 Jan 2026 - Revenue dropped 60% in 2024, but margin gains and new initiatives support a 2025 rebound.DRCT
Q4 202426 Dec 2025 - Shareholders to vote on reverse split, major share issuances, and incentive plan expansion.DRCT
Proxy Filing18 Dec 2025 - Shareholders to vote on reverse split, major share issuances, and incentive plan expansion.DRCT
Proxy Filing15 Dec 2025 - Shareholders to vote on increasing authorized shares and issuing up to 50M new shares for capital flexibility.DRCT
Proxy Filing2 Dec 2025 - Board seeks approval for director elections, auditor, incentive plan, and governance amendments.DRCT
Proxy Filing2 Dec 2025